Abstract: Human G-protein-coupled formyl peptide receptor-like 1 and its mouse homologue formyl peptide receptor 2 (mFPR2) mediate the chemotactic activity of a variety of pathogen and host-derived peptides, including amyloid ␤ 42 , a key causative factor in Alzheimer's disease. In mouse microglia, mFPR2 is up-regulated by pathogen-associated molecular patterns and proinflammatory cytokines, as shown, for instance, in our previous study using peptidoglycan ( 
INTRODUCTION
Microglial cells are key sensors of pathological stimulants in the brain and accumulate at the sites of infection and inflammation by recognizing chemotactic mediators through cell surface receptors [1] . Recently, a G-protein-coupled amyloid ␤ 42 (A␤ 42 ) peptide receptor mouse homologue formyl peptide receptor 2 (mFPR2) has been shown to be expressed by activated microglial cells and implicated in the pathogenesis of Alzheimer's disease (AD) [2] [3] [4] [5] [6] . The human homologue of mFPR2, formyl peptide receptor-like 1 (FPRL1), was originally identified as a low-affinity receptor for the bacterial chemotactic peptide formyl-methionyl-leucyl-phenylalanine [7, 8] . FPRL1 also contributes to the internalization of A␤ 42 into the cytoplasmic compartment of macrophages, where A␤ 42 forms fibrillary aggregates [8, 9] . The expression of the FPRL1 counterpart mFPR2 by mouse primary microglia was enhanced when the cells were activated by ligands for TLRs such as LPS (TLR4), CpG (TLR9), and peptidoglycan (PGN; TLR2), as well as by the proinflammatory cytokines TNF-␣ and IFN-␥ [2-4, 6, 10] . In addition, the mFPR2 expression in microglia was synergistically increased by costimulation with CD40 ligand and IFN-␥ [10] . Thus, the expression of mFPR2 in microglial cells is tightly regulated by pathogen-and host-derived molecules associated with inflammatory and innate immune responses.
Nucleotide-binding oligomerization domain 2 (NOD2) contains three distinct regions: a leucine-rich pattern-recognition domain similar to TLRs, a nucleotide-binding domain that is essential for oligomerization and subsequent signaling, and effector motifs such as the caspase-recruitment domain [11, 12] . NOD2 is involved in intracellular recognition of pathogens and their products, such as muramyldipeptide (MDP; N-acetylmuramyl-l-alanyl-d-isoglutamine) from bacteria [12] . In the CNS, ligation of TLRs and NOD2 by different pathogen-associated molecular patterns in microglial cells initiates intracellular signaling cascades, resulting in a proinflammatory phenotype.
To examine the potential, cooperative role of NOD2 and TLR2 in CNS inflammation and immune responses, we stimulated mouse microglial cells with a combination of ligands for NOD2 and TLR2 and measured the expression and function of mFPR2. We found that MDP and TLR2 ligands, palmitoylcys[(RS)-2, 3-di(palmitoyloxy)-propyl]-Ala-Gly-OH (PamCAG), palmitoyl-3-cysteine-serine-lysine-4 (Pam3CSK4), and PGN, respectively, each up-regulated the expression of functional mFPR2 in microglial cells. In addition, by increasing cell surface TLR2 expression and the levels of activated MAPKs p-38, ERK1/2, and IB␣, MDP primes microglial cells and increases mFPR2 expression induced by TLR2 ligands.
MATERIALS AND METHODS

Reagents and cells
Synthesized PamCAG was from Bachem (King of Prussia, PA, USA). Pam3CSK4, MDP, MDP control, PGN, and IL-10 were purchased from InvivoGen (San Diego, CA, USA). The mFPR2 agonist peptides MMK-1 and W-peptide (WKYMVm, W pep) were synthesized and purified at the Department of Biochemistry, Colorado State University (Fort Collins, CO, USA), according to the published sequence [13] . LPS were purchased from Sigma Chemical Co. (St. Louis, MO, USA). A␤ 42 peptide was from California Peptide Research (Napa, CA, USA). Antibodies specific for total ERK1/2, ERK1/2 phosphorylated at Tyr-204, phospho-p38 MAPK, total p38 MAPK, phosphoAkt, total Akt, phosphorylated IB␣, and total IB␣ were purchased from Cell Signaling Technology (Beverly, MA, USA). SB202190, PD98059, BAY117082, and LY294002 were obtained from Calbiochem (San Diego, CA, USA). The murine microglial cell line N9 [14, 15] was a kind gift from Dr. Paola Ricciardi-Castagnoli (Universita Degli Studi di Milano-Bicocca, Milan, Italy). The cells were grown in IMDM supplemented with 5% heat-inactivated FCS, 2 mM glutamine, 100 units/ml penicillin, 100 g/ml streptomycin, and 50 M 2-ME. Primary murine microglial cells were isolated from 1-day-old newborn C57BL/6 mice or TLR2Ϫ/Ϫ mice [a kind gift from Drs. Shaobo Su and Rachel R. Caspi, Laboratory of Immunology, National Eye Institute, National Institutes of Health (NIH), Bethesda, MD, USA, and Dr. Shizuo Akira, Osaka University, Japan], as described [3] . Primary murine microglial cells were grown in DMEM supplemented with 10% heat-inactivated FCS, 100 U/ml penicillin, 100 g/ml streptomycin, 1 M HEPES, 2.5 g/ml Fungizone, 100 M nonessential amino acids, and 5 g/ml insulin. The purity of the neonatal microglial cell population was determined by the expression of CD11b using flow cytometry as more than 95% [3] .
Chemotaxis assays
Chemotaxis assays for microglial cells were performed with 48-well chemotaxis chambers and polycarbonate filters (8 m pore size; NeuroProbe, Cabin John, MD, USA) as described previously [4] . The results were expressed as the mean Ϯ SD of the chemotaxis index (CI), which represents the fold increase in the number of migrated cells, counted in three high-powered fields (ϫ400), in response to chemoattractants over spontaneous cell migration (to control medium).
RT-PCR
Total RNA was extracted from cells with a RNeasy mini kit and depleted of contaminating DNA with RNase-free DNase (Qiagen, Valencia, CA, USA). For amplification of the mFPR2 gene, primers 5Ј-TCTACCATCTCCAGAGTTCT-GTTGG-3Ј (sense) and 5Ј-TACATCTACCACAATGTGAACTA-3Ј (antisense) were designed to yield a 268-bp product. Mouse ␤-actin primers were used as control; the mouse ␤-actin primers were 5Ј-TGTGATGGTGGGAAT-GGGTCA-3Ј (sense) and 5Ј-TTTGATGTGACGCACGATTTCCC-3Ј (antisense), which yield a product of 514 bp. RT-PCR was performed with 0.5 g (mFPR2) of total RNA for each sample (High Fidelity ProSTAR HF System, Stratagene, La Jolla, CA, USA), consisting of a 15-min RT at 42°C, a 1-min inactivation of Moloney murine leukemia virus RT at 95°C, 40 cycles of denaturing at 95°C (45 s), annealing at 55°C (45 s), extension at 72°C (1 min), and a final extension for 10 min at 72°C. All PCR products were resolved by 1.5% agarose gel electrophoresis and visualized with ethidium bromide staining. For quantitation, gels were scanned, and the pixel intensity for each band was determined using the ImageJ program (NIH Image, Bethesda, MD, USA) and normalized against the levels of ␤-actin.
Flow cytometry
The microglial N9 cell line was stimulated with MDP or PamCAG or in combination with PamCAG, then were examined for expression of TLR2 by labeling with PE-conjugated mAb (PharMingen, San Diego, CA, USA). All staining procedures were completed at 4°C in Dulbecco's PBS containing 5 mM EDTA and 1% FCS. After extensive washing, the cells were analyzed using a FACScan flow cytometer (BD Biosciences, San Jose, CA, USA). The results are presented as percentage of positive cells and mean fluorescence intensity (MFI).
Western immunoblotting
N9 cells were grown in 60-mm dishes until subconfluency and then were cultured overnight in FCS-free medium. After treatment with MDP and TLR2 agonists, the cells were lysed with 1ϫ SDS sample buffer [62.5 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, 50 mM DTT], sonicated for 15 s, and then heated at 100°C for 5 min. The cell lysate was centrifuged at 12,000 rpm (4°C) for 5 min, and the protein concentration of the supernatant was measured by the Micro bicinchoninic acid protein assay system (Pierce, Rockford, IL, USA). Western blotting of phosphorylated p38, ERK1/2, IB␣, and Akt was performed according to the manufacturer's instructions using phospho-specific antibodies. Briefly, proteins were electrophoresed on 10% SDS-PAGE-precast gels (Invitrogen, Carisbad, CA, USA) under reducing conditions and transferred onto an ImmunoBlot polyvinylidene membrane (Bio-Rad, Hercules, CA, USA). The membranes were blocked with 5% nonfat milk and then were incubated with primary antibodies overnight at 4°C. After incubation with a HRP-conjugated secondary antibody, the protein bands were detected with a Super Signal chemiluminescent substrate (Pierce) and Biomax-MR film (Eastman Kodak Co., Rochester, NY, USA). For detection of total p38, ERK1/2, IB␣, and Akt, the membranes were stripped with Restore Western blot stripping buffer (Pierce), followed by incubation with specific antibodies.
Statistical analysis
All experiments were performed at least three times, and representative results were shown. For cell migration, the significance of the difference between test and control groups was analyzed with Student's t-test aided by the Prism software (Prism Software Corp., Irvine, CA, USA), and P values equal to or less than 0.05 were considered statistically significant.
RESULTS
The expression of functional mFPR2 by TLR2 ligand-stimulated murine microglia
We have reported previously that PGN, one of the TLR2 ligands, up-regulated the expression of functional mFPR2 in microglia [4] . As PGN may also activate NOD2, an intracellular pattern recognition receptor (PRR) [12, 16] , we examined the capacity of synthetic, specific TLR2 ligands, PamCAG, and Pam3CSK4 to promote the expression of mFPR2. The mouse microglial cell line N9 treated with PamCAG, Pam3CSK4, and PGN increased their expression of mFPR2 mRNA (Fig. 1A) in association with cell migration to mFPR2 agonist peptides (Fig.  1 , B and C). Maximal activity of PamCAG, Pam3CSK4, and PGN was observed at 20 g/ml with significant effects at 5 g/ml (Fig. 1B) . Similar observations were obtained with the use of primary microglial cells, as shown by up-regulation of mFPR2 mRNA by PamCAG and increased cell migration to a defined mFPR2 agonist peptide MMK-1 (Fig. 1, D 
and E).
Activation of NOD2 induces the expression of functional mFPR2 in microglia NOD2 and TLRs represent two classes of PRRs in the innate immune system. Recently, NOD2 has emerged as one of the central players in the innate immune responses [12, 16] . We found that MDP, a NOD2 ligand, induced mFPR2 expression in N9 and primary microglial cells, which showed increased chemotaxis to mFPR2 agonist peptides (Fig. 2, A and B) . As MDP is the minimal bioactive PGN motif, we examined the possibility for MDP to activate TLR2. We used mouse (m)TLR2Ϫ/Ϫ primary microglial cells and found that when stimulated with PamCAG, these cells did not express increased levels of mFPR2 mRNA (data not shown) nor migrated to mFPR2 agonist peptides (Fig. 2C) . In contrast, mTLR2Ϫ/Ϫ primary microglial cells migrated in response to the mFPR2 agonist peptide after stimulation with LPS (Fig. 2C) or MDP (Fig. 2D) , suggesting that MDP alone induces the expression of functional mFPR2 by activating a receptor other than TLR2.
Cooperation between NOD2 and TLR2 in the upregulation of functional mFPR2 in microglia
We then examined whether activation of NOD2 increases microglial cell responses to TLR2 agonists. We found that the NOD2 agonist MDP was able to prime microglial cell responses to suboptimal concentrations of TLR2 agonists. For instance, the N9 cell line pretreated with MDP (20 g/ml) followed by PamCAG at 5 g/ml additively increased mFPR2 mRNA expression as compared with stimulation with MDP or PamCAG alone (Fig. 3A) . A similar effect was observed with another TLR2 agonist Pam3CSK4 as well as PGN (Fig. 3A) . The increase in mFPR2 mRNA was associated with significantly enhanced cell chemotaxis in response to mFPR2 agonist peptides. The cell chemotaxis was more prominent when the cells were treated with NOD2 and TLR2 ligands, as compared with cells treated with NOD2 or TLR2 ligands alone (Fig. 3, B and C) . Thus, NOD2 agonist MDP primed the microglial cell response to TLR2 ligands by increased expression of functional mFPR2. 
Activation of NOD2 enhances TLR2 expression on microglial cells
To elucidate the mechanisms of the additive effects shown by MDP and PamCAG on up-regulation of mFPR2 in microglia, we examined the capacity of MDP to regulate the expression level of TLR2. N9 cells constitutively expressed TLR2 on the cell surface, as shown by a high percentage of the TLR2-positive cell pool (Fig.  4) . Stimulation of the cells with TLR2 or NOD2 ligands had little effect on TLR2 positivity, but rather, each ligand significantly increased the density of TLR2 fluorescence (MFI). There was a marked increase in MFI when the cells were treated with a combination of stimulation of MDP and PamCAG as compared with stimulation with a single ligand (Fig. 4) , suggesting further elevation of TLR2 density on the cell surface. These results indicate that MDP enhanced the level of TLR2 expression on microglia, which may account for its costimulatory effect with PamCAG to promote mFPR2 expression.
Requirement of NOD2 for MDP to up-regulate TLR2 and to further enhance mFPR2 expression induced by TLR2 ligands MDP recognition by NOD2 is highly stereospecific for the L-D isomer [17] . The core structure required for recognition of NOD2 is N-acetylmuramic acid attached to L-Ala and DisoGln. Replacement of L-Ala by D-Ala (or D-isoGln by LisoGln) abolishes the ability of the MDP to stimulate NOD2. We found that the D-D isomer of MDP (MDP control) failed to up-regulate TLR2 (Fig. 5A) or to further enhance TLR2 ligand-induced mFPR2 expression in murine microglial cells (Fig. 5, B and C) . The results demonstrate that the activation of NOD2 is restricted to the L-D isomer of MDP.
We also tested the effect of IL-10, which has been reported to specifically induce an endogenous NOD2 inhibitor, NOD2-S, in mammalian cells [18] . N9 cells pretreated with IL-10 followed with MDP showed reduced expression of functional mFPR2 when further stimulated with TLR2 ligands (Fig.  5, D and E) , indicating the key role of NOD2 in mediating the priming effect of MDP on microglial responses to TLR2 agonists.
Enhanced activation level of MAPKs and IB␣ in microglial cells costimulated by NOD2 and TLR2 ligands
We have previously reported the requirement of p38 and ERK1/2 MAPK pathways and IB␣ activation in the induction of mFPR2 by PGN in microglial cells [4] . We confirmed that the capacity of the specific TLR2 agonist PamCAG to upregulate mFPR2 in microglial cells was indeed dependent on p38, ERK1/2, MAPK, and IB␣ activation as shown by reduction of the effect of PamCAG by specific inhibitors (Fig. 6A) . The effect of TLR2 ligands on mFPR2 up-regulation in microglia was not dependent on PI3K, as the cells incubated with the specific PI3K inhibitor LY294002 maintained their responses to PamCAG (Fig. 6A) . We also found that Pam3CSK4 is more potent among TLR2 ligands tested in stimulating MAPK and IB␣ activation (Fig. 6B) . We then further investigated the Fig. 2 . mFPR2 function in microglia stimulated with NOD2 or TLR2 agonists. N9 microglial cells were incubated with NOD2 agonist MDP (20 g/ml) at 37°C for 24 h and then were examined for cell chemotaxis to the mFPR2 agonist peptide W-peptide (10 Ϫ6 M; A). Primary microglia from TLR2ϩ/ϩ mice were also treated with NOD2 agonist MDP (20 g/ml) at 37°C for 24 h and then were examined for cell chemotaxis to the mFPR2 agonist peptide MMK-1 (10 Ϫ4 M; B). Primary microglia from TLR2Ϫ/Ϫ or TLR2ϩ/ϩ mice were treated with PamCAG (20 g/ml) or LPS (0.5 g/ml) at 37°C for 24 h (C) or with MDP (20 g/ml) at 37°C for 24 h (D) and then examined for migration in response to the mFPR2 agonist peptide MMK-1 (10 Ϫ4 M). The results of chemotaxis were expressed as CI. *, Statistically significant (PϽ0.01) increase in cell migration induced by mFPR2 agonist peptides, as compared with unstimulated cells.
signaling pathways involved in the cooperative effect of NOD2 and TLR2 on N9 cells. Treatment of the cells with PamCAG alone induced phosphorylation of p38, Akt, and ERK1/2 at 30 min, and activation of IB␣ was barely detectable at 60 min (Fig. 6C) . When N9 cells were treated with MDP alone, phosphorylation of p38 and Akt was detectable at 5 min, followed by a marked increase at 60 min. MDP also induced the phosphorylation of ERK1/2 at 60 min but without apparent phosphorylation of IB␣ (Fig. 6D) . In contrast, microglial cells pretreated with MDP followed by PamCAG showed a more rapid phosphorylation of p38 and ERK1/2 (Fig. 6E) . The phosphorylation of IB␣ was also enhanced significantly at 60 min after microglia were stimulated with MDP and PamCAG (Fig. 6E) . The changes in the levels of total IB␣ in microglial cells stimulated by MDP and PamCAG alone or in combination were presumably a result of dynamic degradation and de novo synthesis of the molecule (Fig. 6E) . Thus, NOD2 and TLR2 costimulation triggered a more rapid and/or efficient intracellular signaling cascade in microglial cells, which may be responsible for the cooperative effect between NOD2 and TLR2 on mFPR2 up-regulation. /ml) , or MDP (20 g/ml) and PamCAG (5 g/ml) in combination for 24 h and then were examined for migration in response to A␤ 42 (75 g/ml) or W-peptide (10 Ϫ6 M). (C) N9 cells were stimulated with MDP (20 g/ml), Pam3CSK4 (5 g/ml), or PGN (5 g/ml) or were pretreated with MDP (20 g/ml) for 5 h followed by Pam3CSK4 (5 g/ml) or PGN (5 g/ml) for 24 h and then were examined for migration in response to W-peptide (10 Ϫ6 M). The results are expressed as CI. # , Significantly (PϽ0.05) increased migration of cells treated with PamCAG, Pam3CSK4, or PGN in response to mFPR2 agonist peptide compared with spontaneous cell migration (to medium). *, Significantly (PϽ0.01) increased migration of microglia treated with a combination of MDP with TLR2 agonists in response to mFPR2 agonist peptides as compared with cells treated with MDP or TLR2 agonists alone (Band). 
DISCUSSION
In this study, we showed for the first time that NOD2 and TLR2, two PRRs, cooperate in transmitting signals necessary for induction of the G-protein-coupled receptor mFPR2 in microglial cells. As a consequence, microglial cells exhibited markedly increased chemotaxis in response to exogenous and host-derived mFPR2 agonist peptides.
Microglia are resident mononuclear phagocytes in the CNS and are key mediators of innate immune responses and inflammation in the brain [19, 20] . In fact, activation of microglia is an essential component in the pathogenesis of many CNS diseases, including AD, Parkinson's disease [21] , multiple sclerosis, and AIDS dementia [22] . Our previous studies showed that murine microglial cells in the nonstimulated state express low levels of mFPR2 [2-4, 6, 10] . When stimulated with LPS, PGN, and CpG, the level of mFPR2 is enhanced, and the cells become more responsive to mFPR2-specific agonists [3, 4, 6] , suggesting that activation of TLR4, TLR2, and TLR9 may promote microglial responses in CNS diseases. Activation of mFPR2 and human FPRL1 in phagocytic leukocytes by their peptide agonists elicits typical proinflammatory responses, including increased cell chemotaxis, phagocytoses, and release of superoxide [23, 24] . Our present study reveals that activation of NOD2 or TLR2 alone increased mFPR2 expression and function in microglial cells, and cells primed with MDP showed enhanced expression of TLR2 and a more efficacious induction of mFPR2 by TLR2 ligands. Thus, TLR2 and NOD2, two classes of PRRs in the innate immune system, are able to cooperate in orchestrating host responses in the CNS. mFPR2 and its human homologue FPRL1 recognize bacterial and host-derived chemotactic agonist peptides, including A␤ 42 associated with AD [2-6, 10, 24, 25] .
It should be noted that our study found that the reversed A␤ 42 , A␤ 42-1 did not activate mFPR2 or human FPRL1. Also, although the 40-aa form of A␤, A␤ 40 , has been reported to increase its production in AD, our study showed A␤ 40 was a poor agonist of FPRL1 or mFPR2 and thus, may not play a major role in inducing microglial chemotaxis and activation [9, 25] .
MDP has been reported to increase TNF-␣ production induced by LPS or PGN in a macrophage cell line [26] , and MDP synergizes with tripalmitoyl-S-glyceryl cysteine in stimulating the production of TNF-␣, IL-1␤, and IL-10 in mononuclear cells from healthy donors [27] . In rat primary microglial cells, P2X4 receptor was up-regulated after stimulation with Pam3CSK4 or LPS in combination with MDP [28] . Synergy between NOD2 and TLRs also has been observed in dendritic cells (DCs) [29] . MDP in combination with TLR4-agonistic lipid A, TLR3-agonistic polyinosinic:polycytidylic acid, or TLR9-agonistic CpG DNA synergistically induced IL-12 and IFN-␥ production in human DCs to promote Th1 responses [29] . MDP priming of mice induced hyper-responsiveness to endotoxin and other bacterial products interacting with TLRs, although MDP by itself showed little activity [30, 31] . Our study demonstrating cooperation between NOD2 and TLR2 in induction of mFPR2 in microglial cells reveals a novel role of these molecules in CNS innate immunology. In addition, we have identified key signal transduction molecules involved in the cooperation of NOD2 and TLR2 in microglial cells. /ml) , or PGN (20 g/ml) at 37°C and then were lysed at the indicated time-points. Equal amounts of total proteins were electrophoresed and blotted. Protein bands were detected with antiphospho (P)-p38 and -ERK1/2 and IB␣. Total Akt bands were used as loading controls. (C-E) N9 cells were stimulated with PamCAG (5 g/ml; C) or MDP (20 g/ml; D), or the cells were pretreated with MDP (20 g/ml) for 5 h, followed with PamCAG (5 g/ml; E) for different time periods (min). Whole cell lysates were electrophoresed, and Western immunoblotting was performed using antibodies against phospho-p38, -ERK1/2, -IB␣, and -Akt, respectively. The membranes were then stripped and reprobed with antibodies against total p38, ERK, IB␣, and Akt.
Mouse microglia stimulated with agonists for TLR4 [3] , TLR2 [4] , and TLR9 [6] not only exhibited increased chemotactic responses to A␤ 42 but also, a markedly enhanced uptake of A␤ 42 mediated by mFPR2 [4 -6, 10, 24] . Recent studies have shown that TLR activation is essential for microglial cells to acquire the capacity to ingest and process A␤ 42 , presumably via mFPR2 [32] . In this context, the effect of TLRs was almost completely inhibited by pertussis toxin, a deactivator of Gprotein-coupled receptors including mFPR2 [32] . Other molecules that interact with TLR4 such as Hsp90, Hsp70, and Hsp32 also increased the accumulation of A␤ peptides in microglia [24, 33] . Thus, TLRs in microglia by interacting with host-or pathogen-derived ligands may initiate a protective host response to A␤ 42 peptides. Indeed, in mouse AD models, injection of LPS activates microglia and reduces A␤ burden in the hippocampus [34] . However, it should be pointed out that other studies also have shown an essential role for microglia to lay down A␤ peptides to form aggregates, and in addition, the A␤ peptide activates mFPR2 or human FPRL1 to promote a proinflammatory response. Therefore, the clearance and deposition of A␤ peptides by microglial cells in the pathogenic process of AD may be dynamic and dependent on multiple factors including the state of microglial activation, the levels of TLRs and mFPR2, as well as A␤ peptide burden. Our study suggests the importance of amplifying the beneficial effects of microglial activation in host defense against noxious agents and to minimize the potential, detrimental impact of an undesirable level of inflammation.
